APO Research
Talk to an analyst

APO RESEARCH · REPORT

Gastrointestinal OTC Drugs

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Gastrointestinal OTC Drugs Market Outlook and Growth Opportunities 2026

20 December 2025194 pages

Choose your research edition.

Industry ResearchGastrointestinal OTC Drugs Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Gastrointestinal OTC Drugs Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Gastrointestinal OTC Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gastrointestinal OTC Drugs Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Gastrointestinal OTC Drugs Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Gastrointestinal OTC Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Gastrointestinal OTC Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Gastrointestinal OTC Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Gastrointestinal OTC Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Gastrointestinal OTC Drugs market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Gastrointestinal OTC Drugs market include Boehringer Ingelheim, Perrigo, Procter & Gamble, Purdue Pharma, Reckitt Benckiser, Bayer, GlaxoSmithKline, Pfizer and Johnson & Johnson, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Gastrointestinal OTC Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Gastrointestinal OTC Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Gastrointestinal OTC Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Gastrointestinal OTC Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Gastrointestinal OTC Drugs Segment by Company

Boehringer Ingelheim

Perrigo

Procter & Gamble

Purdue Pharma

Reckitt Benckiser

Bayer

GlaxoSmithKline

Pfizer

Johnson & Johnson

Nestle

Sanofi

Teva Pharmaceutical

Abbott

Gastrointestinal OTC Drugs Segment by Type

Anti-Emetics

Laxatives

Anti-Flatulents

Anti-Diarrheals

PPIs

H2-Antaginists

Other

Gastrointestinal OTC Drugs Segment by Application

Retail Pharmacies

Online Pharmacies

Hospital Pharmacies

Gastrointestinal OTC Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Gastrointestinal OTC Drugs status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Gastrointestinal OTC Drugs market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Gastrointestinal OTC Drugs significant trends, drivers, influence factors in global and regions.

6. To analyze Gastrointestinal OTC Drugs competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gastrointestinal OTC Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gastrointestinal OTC Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gastrointestinal OTC Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Gastrointestinal OTC Drugs market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Gastrointestinal OTC Drugs industry.

Chapter 3: Detailed analysis of Gastrointestinal OTC Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Gastrointestinal OTC Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Gastrointestinal OTC Drugs in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Gastrointestinal OTC Drugs Industry Trends Table 2. Gastrointestinal OTC Drugs Industry Drivers Table 3. Gastrointestinal OTC Drugs Industry Opportunities and Challenges Table 4. Gastrointestinal OTC Drugs Industry Restraints Table 5. Global Gastrointestinal OTC Drugs Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Gastrointestinal OTC Drugs Revenue Share by Company (2021-2026) Table 7. Global Gastrointestinal OTC Drugs Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Gastrointestinal OTC Drugs Sales Volume Share by Company (2021-2026) Table 9. Global Gastrointestinal OTC Drugs Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Gastrointestinal OTC Drugs Company Ranking, (2024-2026) & (USD Million) Table 11. Global Gastrointestinal OTC Drugs Key Company Manufacturing Base & Headquarters Table 12. Global Gastrointestinal OTC Drugs Company, Product Type & Application Table 13. Global Gastrointestinal OTC Drugs Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Gastrointestinal OTC Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Anti-Emetics Table 18. Significant Companies of Laxatives Table 19. Significant Companies of Anti-Flatulents Table 20. Significant Companies of Anti-Diarrheals Table 21. Significant Companies of PPIs Table 22. Significant Companies of H2-Antaginists Table 23. Significant Companies of Other Table 24. Global Gastrointestinal OTC Drugs Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 25. Global Gastrointestinal OTC Drugs Sales Volume by Type (2021-2026) & (K Units) Table 26. Global Gastrointestinal OTC Drugs Sales Volume by Type (2027-2032) & (K Units) Table 27. Global Gastrointestinal OTC Drugs Sales Volume Share by Type (2021-2026) Table 28. Global Gastrointestinal OTC Drugs Sales Volume Share by Type (2027-2032) Table 29. Global Gastrointestinal OTC Drugs Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Gastrointestinal OTC Drugs Sales Value by Type (2021-2026) & (US$ Million) Table 31. Global Gastrointestinal OTC Drugs Sales Value by Type (2027-2032) & (US$ Million) Table 32. Global Gastrointestinal OTC Drugs Sales Value Share by Type (2021-2026) Table 33. Global Gastrointestinal OTC Drugs Sales Value Share by Type (2027-2032) Table 34. Significant Companies of Retail Pharmacies Table 35. Significant Companies of Online Pharmacies Table 36. Significant Companies of Hospital Pharmacies Table 37. Global Gastrointestinal OTC Drugs Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 38. Global Gastrointestinal OTC Drugs Sales Volume by Application (2021-2026) & (K Units) Table 39. Global Gastrointestinal OTC Drugs Sales Volume by Application (2027-2032) & (K Units) Table 40. Global Gastrointestinal OTC Drugs Sales Volume Share by Application (2021-2026) Table 41. Global Gastrointestinal OTC Drugs Sales Volume Share by Application (2027-2032) Table 42. Global Gastrointestinal OTC Drugs Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 43. Global Gastrointestinal OTC Drugs Sales Value by Application (2021-2026) & (US$ Million) Table 44. Global Gastrointestinal OTC Drugs Sales Value by Application (2027-2032) & (US$ Million) Table 45. Global Gastrointestinal OTC Drugs Sales Value Share by Application (2021-2026) Table 46. Global Gastrointestinal OTC Drugs Sales Value Share by Application (2027-2032) Table 47. Global Gastrointestinal OTC Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 48. Global Gastrointestinal OTC Drugs Sales by Region (2021-2026) & (K Units) Table 49. Global Gastrointestinal OTC Drugs Sales Market Share by Region (2021-2026) Table 50. Global Gastrointestinal OTC Drugs Sales by Region (2027-2032) & (K Units) Table 51. Global Gastrointestinal OTC Drugs Sales Market Share by Region (2027-2032) Table 52. Global Gastrointestinal OTC Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 53. Global Gastrointestinal OTC Drugs Sales Value by Region (2021-2026) & (US$ Million) Table 54. Global Gastrointestinal OTC Drugs Sales Value Share by Region (2021-2026) Table 55. Global Gastrointestinal OTC Drugs Sales Value by Region (2027-2032) & (US$ Million) Table 56. Global Gastrointestinal OTC Drugs Sales Value Share by Region (2027-2032) Table 57. Global Gastrointestinal OTC Drugs Market Average Price (US$/Unit) by Region (2021-2026) Table 58. Global Gastrointestinal OTC Drugs Market Average Price (US$/Unit) by Region (2027-2032) Table 59. Global Gastrointestinal OTC Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 60. Global Gastrointestinal OTC Drugs Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Gastrointestinal OTC Drugs Sales by Country (2021-2026) & (K Units) Table 62. Global Gastrointestinal OTC Drugs Sales Market Share by Country (2021-2026) Table 63. Global Gastrointestinal OTC Drugs Sales by Country (2027-2032) & (K Units) Table 64. Global Gastrointestinal OTC Drugs Sales Market Share by Country (2027-2032) Table 65. Global Gastrointestinal OTC Drugs Sales Value by Country (2021-2026) & (US$ Million) Table 66. Global Gastrointestinal OTC Drugs Sales Value Market Share by Country (2021-2026) Table 67. Global Gastrointestinal OTC Drugs Sales Value by Country (2027-2032) & (US$ Million) Table 68. Global Gastrointestinal OTC Drugs Sales Value Market Share by Country (2027-2032) Table 69. Boehringer Ingelheim Company Information Table 70. Boehringer Ingelheim Business Overview Table 71. Boehringer Ingelheim Gastrointestinal OTC Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Boehringer Ingelheim Gastrointestinal OTC Drugs Product Portfolio Table 73. Boehringer Ingelheim Recent Development Table 74. Perrigo Company Information Table 75. Perrigo Business Overview Table 76. Perrigo Gastrointestinal OTC Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Perrigo Gastrointestinal OTC Drugs Product Portfolio Table 78. Perrigo Recent Development Table 79. Procter & Gamble Company Information Table 80. Procter & Gamble Business Overview Table 81. Procter & Gamble Gastrointestinal OTC Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Procter & Gamble Gastrointestinal OTC Drugs Product Portfolio Table 83. Procter & Gamble Recent Development Table 84. Purdue Pharma Company Information Table 85. Purdue Pharma Business Overview Table 86. Purdue Pharma Gastrointestinal OTC Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Purdue Pharma Gastrointestinal OTC Drugs Product Portfolio Table 88. Purdue Pharma Recent Development Table 89. Reckitt Benckiser Company Information Table 90. Reckitt Benckiser Business Overview Table 91. Reckitt Benckiser Gastrointestinal OTC Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Reckitt Benckiser Gastrointestinal OTC Drugs Product Portfolio Table 93. Reckitt Benckiser Recent Development Table 94. Bayer Company Information Table 95. Bayer Business Overview Table 96. Bayer Gastrointestinal OTC Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Bayer Gastrointestinal OTC Drugs Product Portfolio Table 98. Bayer Recent Development Table 99. GlaxoSmithKline Company Information Table 100. GlaxoSmithKline Business Overview Table 101. GlaxoSmithKline Gastrointestinal OTC Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. GlaxoSmithKline Gastrointestinal OTC Drugs Product Portfolio Table 103. GlaxoSmithKline Recent Development Table 104. Pfizer Company Information Table 105. Pfizer Business Overview Table 106. Pfizer Gastrointestinal OTC Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Pfizer Gastrointestinal OTC Drugs Product Portfolio Table 108. Pfizer Recent Development Table 109. Johnson & Johnson Company Information Table 110. Johnson & Johnson Business Overview Table 111. Johnson & Johnson Gastrointestinal OTC Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Johnson & Johnson Gastrointestinal OTC Drugs Product Portfolio Table 113. Johnson & Johnson Recent Development Table 114. Nestle Company Information Table 115. Nestle Business Overview Table 116. Nestle Gastrointestinal OTC Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Nestle Gastrointestinal OTC Drugs Product Portfolio Table 118. Nestle Recent Development Table 119. Sanofi Company Information Table 120. Sanofi Business Overview Table 121. Sanofi Gastrointestinal OTC Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Sanofi Gastrointestinal OTC Drugs Product Portfolio Table 123. Sanofi Recent Development Table 124. Teva Pharmaceutical Company Information Table 125. Teva Pharmaceutical Business Overview Table 126. Teva Pharmaceutical Gastrointestinal OTC Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. Teva Pharmaceutical Gastrointestinal OTC Drugs Product Portfolio Table 128. Teva Pharmaceutical Recent Development Table 129. Abbott Company Information Table 130. Abbott Business Overview Table 131. Abbott Gastrointestinal OTC Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. Abbott Gastrointestinal OTC Drugs Product Portfolio Table 133. Abbott Recent Development Table 134. Key Raw Materials Table 135. Raw Materials Key Suppliers Table 136. Gastrointestinal OTC Drugs Distributors List Table 137. Gastrointestinal OTC Drugs Customers List Table 138. Research Programs/Design for This Report Table 139. Authors List of This Report Table 140. Secondary Sources Table 141. Primary Sources List of Figures Figure 1. Gastrointestinal OTC Drugs Product Image Figure 2. Global Gastrointestinal OTC Drugs Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Gastrointestinal OTC Drugs Sales Value (2021-2032) & (US$ Million) Figure 4. Global Gastrointestinal OTC Drugs Sales (2021-2032) & (K Units) Figure 5. Global Gastrointestinal OTC Drugs Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Gastrointestinal OTC Drugs Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Anti-Emetics Image Figure 10. Laxatives Image Figure 11. Anti-Flatulents Image Figure 12. Anti-Diarrheals Image Figure 13. PPIs Image Figure 14. H2-Antaginists Image Figure 15. Other Image Figure 16. Global Gastrointestinal OTC Drugs Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 17. Global Gastrointestinal OTC Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 18. Global Gastrointestinal OTC Drugs Sales Volume Share by Type (2021-2032) Figure 19. Global Gastrointestinal OTC Drugs Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Gastrointestinal OTC Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 21. Global Gastrointestinal OTC Drugs Sales Value Share by Type (2021-2032) Figure 22. Retail Pharmacies Image Figure 23. Online Pharmacies Image Figure 24. Hospital Pharmacies Image Figure 25. Global Gastrointestinal OTC Drugs Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 26. Global Gastrointestinal OTC Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 27. Global Gastrointestinal OTC Drugs Sales Volume Share by Application (2021-2032) Figure 28. Global Gastrointestinal OTC Drugs Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Gastrointestinal OTC Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 30. Global Gastrointestinal OTC Drugs Sales Value Share by Application (2021-2032) Figure 31. Global Gastrointestinal OTC Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 32. Global Gastrointestinal OTC Drugs Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 33. Global Gastrointestinal OTC Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 34. Global Gastrointestinal OTC Drugs Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 35. North America Gastrointestinal OTC Drugs Sales Value (2021-2032) & (US$ Million) Figure 36. North America Gastrointestinal OTC Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Europe Gastrointestinal OTC Drugs Sales Value (2021-2032) & (US$ Million) Figure 38. Europe Gastrointestinal OTC Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Asia-Pacific Gastrointestinal OTC Drugs Sales Value (2021-2032) & (US$ Million) Figure 40. Asia-Pacific Gastrointestinal OTC Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 41. South America Gastrointestinal OTC Drugs Sales Value (2021-2032) & (US$ Million) Figure 42. South America Gastrointestinal OTC Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 43. Middle East & Africa Gastrointestinal OTC Drugs Sales Value (2021-2032) & (US$ Million) Figure 44. Middle East & Africa Gastrointestinal OTC Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 45. USA Gastrointestinal OTC Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. USA Gastrointestinal OTC Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. USA Gastrointestinal OTC Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Canada Gastrointestinal OTC Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Canada Gastrointestinal OTC Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Canada Gastrointestinal OTC Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Mexico Gastrointestinal OTC Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Mexico Gastrointestinal OTC Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Mexico Gastrointestinal OTC Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Germany Gastrointestinal OTC Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Germany Gastrointestinal OTC Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Germany Gastrointestinal OTC Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. France Gastrointestinal OTC Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. France Gastrointestinal OTC Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. France Gastrointestinal OTC Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. U.K. Gastrointestinal OTC Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. U.K. Gastrointestinal OTC Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. U.K. Gastrointestinal OTC Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Italy Gastrointestinal OTC Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Italy Gastrointestinal OTC Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Italy Gastrointestinal OTC Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Spain Gastrointestinal OTC Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Spain Gastrointestinal OTC Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Spain Gastrointestinal OTC Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Russia Gastrointestinal OTC Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Russia Gastrointestinal OTC Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Russia Gastrointestinal OTC Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Netherlands Gastrointestinal OTC Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Netherlands Gastrointestinal OTC Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Netherlands Gastrointestinal OTC Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Nordic Countries Gastrointestinal OTC Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Nordic Countries Gastrointestinal OTC Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Nordic Countries Gastrointestinal OTC Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. China Gastrointestinal OTC Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. China Gastrointestinal OTC Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. China Gastrointestinal OTC Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Japan Gastrointestinal OTC Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Japan Gastrointestinal OTC Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Japan Gastrointestinal OTC Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. South Korea Gastrointestinal OTC Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. South Korea Gastrointestinal OTC Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. South Korea Gastrointestinal OTC Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. India Gastrointestinal OTC Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. India Gastrointestinal OTC Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. India Gastrointestinal OTC Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Australia Gastrointestinal OTC Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Australia Gastrointestinal OTC Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Australia Gastrointestinal OTC Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Southeast Asia Gastrointestinal OTC Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Southeast Asia Gastrointestinal OTC Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Southeast Asia Gastrointestinal OTC Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Brazil Gastrointestinal OTC Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Brazil Gastrointestinal OTC Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Brazil Gastrointestinal OTC Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Argentina Gastrointestinal OTC Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Argentina Gastrointestinal OTC Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Argentina Gastrointestinal OTC Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Chile Gastrointestinal OTC Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Chile Gastrointestinal OTC Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Chile Gastrointestinal OTC Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Colombia Gastrointestinal OTC Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Colombia Gastrointestinal OTC Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Colombia Gastrointestinal OTC Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Peru Gastrointestinal OTC Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Peru Gastrointestinal OTC Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Peru Gastrointestinal OTC Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Gastrointestinal OTC Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Saudi Arabia Gastrointestinal OTC Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Saudi Arabia Gastrointestinal OTC Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Israel Gastrointestinal OTC Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Israel Arabia Gastrointestinal OTC Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Israel Arabia Gastrointestinal OTC Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. UAE Gastrointestinal OTC Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. UAE Gastrointestinal OTC Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. UAE Gastrointestinal OTC Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Turkey Gastrointestinal OTC Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Turkey Gastrointestinal OTC Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Turkey Gastrointestinal OTC Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Iran Gastrointestinal OTC Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Iran Gastrointestinal OTC Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Iran Gastrointestinal OTC Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Egypt Gastrointestinal OTC Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 127. Egypt Gastrointestinal OTC Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 128. Egypt Gastrointestinal OTC Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 129. Gastrointestinal OTC Drugs Value Chain Figure 130. Manufacturing Cost Structure Figure 131. Gastrointestinal OTC Drugs Sales Mode & Process Figure 132. Direct Comparison with Distribution Share Figure 133. Distributors Profiles Figure 134. Years Considered Figure 135. Research Process Figure 136. Key Executives Interviewed

Scope & coverage.

Types
  • Anti-Emetics
  • Laxatives
  • Anti-Flatulents
  • Anti-Diarrheals
  • PPIs
  • H2-Antaginists
  • Other
Applications
  • Retail Pharmacies
  • Online Pharmacies
  • Hospital Pharmacies
Companies covered
  • Boehringer Ingelheim
  • Perrigo
  • Procter & Gamble
  • Purdue Pharma
  • Reckitt Benckiser
  • Bayer
  • GlaxoSmithKline
  • Pfizer
  • Johnson & Johnson
  • Nestle
  • Sanofi
  • Teva Pharmaceutical
  • Abbott

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Gastrointestinal OTC Drugs Sales Value (2021-2032)
  4. 1.2.2 Global Gastrointestinal OTC Drugs Sales Volume (2021-2032)
  5. 1.2.3 Global Gastrointestinal OTC Drugs Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Gastrointestinal OTC Drugs Market Dynamics
  1. 2.1 Gastrointestinal OTC Drugs Industry Trends
  2. 2.2 Gastrointestinal OTC Drugs Industry Drivers
  3. 2.3 Gastrointestinal OTC Drugs Industry Opportunities and Challenges
  4. 2.4 Gastrointestinal OTC Drugs Industry Restraints
3 Gastrointestinal OTC Drugs Market by Company
  1. 3.1 Global Gastrointestinal OTC Drugs Company Revenue Ranking in 2025
  2. 3.2 Global Gastrointestinal OTC Drugs Revenue by Company (2021-2026)
  3. 3.3 Global Gastrointestinal OTC Drugs Sales Volume by Company (2021-2026)
  4. 3.4 Global Gastrointestinal OTC Drugs Average Price by Company (2021-2026)
  5. 3.5 Global Gastrointestinal OTC Drugs Company Ranking (2024-2026)
  6. 3.6 Global Gastrointestinal OTC Drugs Company Manufacturing Base and Headquarters
  7. 3.7 Global Gastrointestinal OTC Drugs Company Product Type and Application
  8. 3.8 Global Gastrointestinal OTC Drugs Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Gastrointestinal OTC Drugs Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Gastrointestinal OTC Drugs Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Gastrointestinal OTC Drugs Market by Type
  1. 4.1 Gastrointestinal OTC Drugs Type Introduction
  2. 4.1.1 Anti-Emetics
  3. 4.1.2 Laxatives
  4. 4.1.3 Anti-Flatulents
  5. 4.1.4 Anti-Diarrheals
  6. 4.1.5 PPIs
  7. 4.1.6 H2-Antaginists
  8. 4.1.7 Other
  9. 4.2 Global Gastrointestinal OTC Drugs Sales Volume by Type
  10. 4.2.1 Global Gastrointestinal OTC Drugs Sales Volume by Type (2021 VS 2025 VS 2032)
  11. 4.2.2 Global Gastrointestinal OTC Drugs Sales Volume by Type (2021-2032)
  12. 4.2.3 Global Gastrointestinal OTC Drugs Sales Volume Share by Type (2021-2032)
  13. 4.3 Global Gastrointestinal OTC Drugs Sales Value by Type
  14. 4.3.1 Global Gastrointestinal OTC Drugs Sales Value by Type (2021 VS 2025 VS 2032)
  15. 4.3.2 Global Gastrointestinal OTC Drugs Sales Value by Type (2021-2032)
  16. 4.3.3 Global Gastrointestinal OTC Drugs Sales Value Share by Type (2021-2032)
5 Gastrointestinal OTC Drugs Market by Application
  1. 5.1 Gastrointestinal OTC Drugs Application Introduction
  2. 5.1.1 Retail Pharmacies
  3. 5.1.2 Online Pharmacies
  4. 5.1.3 Hospital Pharmacies
  5. 5.2 Global Gastrointestinal OTC Drugs Sales Volume by Application
  6. 5.2.1 Global Gastrointestinal OTC Drugs Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Gastrointestinal OTC Drugs Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Gastrointestinal OTC Drugs Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Gastrointestinal OTC Drugs Sales Value by Application
  10. 5.3.1 Global Gastrointestinal OTC Drugs Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Gastrointestinal OTC Drugs Sales Value by Application (2021-2032)
  12. 5.3.3 Global Gastrointestinal OTC Drugs Sales Value Share by Application (2021-2032)
6 Gastrointestinal OTC Drugs Regional Sales and Value Analysis
  1. 6.1 Global Gastrointestinal OTC Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Gastrointestinal OTC Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Gastrointestinal OTC Drugs Sales by Region: 2021-2026
  4. 6.2.2 Global Gastrointestinal OTC Drugs Sales by Region (2027-2032)
  5. 6.3 Global Gastrointestinal OTC Drugs Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Gastrointestinal OTC Drugs Sales Value by Region (2021-2032)
  7. 6.4.1 Global Gastrointestinal OTC Drugs Sales Value by Region: 2021-2026
  8. 6.4.2 Global Gastrointestinal OTC Drugs Sales Value by Region (2027-2032)
  9. 6.5 Global Gastrointestinal OTC Drugs Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Gastrointestinal OTC Drugs Sales Value (2021-2032)
  12. 6.6.2 North America Gastrointestinal OTC Drugs Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Gastrointestinal OTC Drugs Sales Value (2021-2032)
  15. 6.7.2 Europe Gastrointestinal OTC Drugs Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Gastrointestinal OTC Drugs Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Gastrointestinal OTC Drugs Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Gastrointestinal OTC Drugs Sales Value (2021-2032)
  21. 6.9.2 South America Gastrointestinal OTC Drugs Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Gastrointestinal OTC Drugs Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Gastrointestinal OTC Drugs Sales Value Share by Country, 2025 VS 2032
7 Gastrointestinal OTC Drugs Country-level Sales and Value Analysis
  1. 7.1 Global Gastrointestinal OTC Drugs Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Gastrointestinal OTC Drugs Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Gastrointestinal OTC Drugs Sales by Country (2021-2032)
  4. 7.3.1 Global Gastrointestinal OTC Drugs Sales by Country (2021-2026)
  5. 7.3.2 Global Gastrointestinal OTC Drugs Sales by Country (2027-2032)
  6. 7.4 Global Gastrointestinal OTC Drugs Sales Value by Country (2021-2032)
  7. 7.4.1 Global Gastrointestinal OTC Drugs Sales Value by Country (2021-2026)
  8. 7.4.2 Global Gastrointestinal OTC Drugs Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Gastrointestinal OTC Drugs Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Gastrointestinal OTC Drugs Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Gastrointestinal OTC Drugs Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Gastrointestinal OTC Drugs Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Gastrointestinal OTC Drugs Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Gastrointestinal OTC Drugs Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Gastrointestinal OTC Drugs Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Gastrointestinal OTC Drugs Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Gastrointestinal OTC Drugs Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Gastrointestinal OTC Drugs Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Gastrointestinal OTC Drugs Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Gastrointestinal OTC Drugs Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Gastrointestinal OTC Drugs Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Gastrointestinal OTC Drugs Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Gastrointestinal OTC Drugs Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Gastrointestinal OTC Drugs Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Gastrointestinal OTC Drugs Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Gastrointestinal OTC Drugs Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Gastrointestinal OTC Drugs Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Gastrointestinal OTC Drugs Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Gastrointestinal OTC Drugs Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Gastrointestinal OTC Drugs Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Gastrointestinal OTC Drugs Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Gastrointestinal OTC Drugs Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Gastrointestinal OTC Drugs Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Gastrointestinal OTC Drugs Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Gastrointestinal OTC Drugs Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Gastrointestinal OTC Drugs Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Gastrointestinal OTC Drugs Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Gastrointestinal OTC Drugs Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Gastrointestinal OTC Drugs Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Gastrointestinal OTC Drugs Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Gastrointestinal OTC Drugs Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Gastrointestinal OTC Drugs Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Gastrointestinal OTC Drugs Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Gastrointestinal OTC Drugs Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Gastrointestinal OTC Drugs Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Gastrointestinal OTC Drugs Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Gastrointestinal OTC Drugs Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Gastrointestinal OTC Drugs Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Gastrointestinal OTC Drugs Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Gastrointestinal OTC Drugs Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Gastrointestinal OTC Drugs Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Gastrointestinal OTC Drugs Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Gastrointestinal OTC Drugs Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Gastrointestinal OTC Drugs Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Gastrointestinal OTC Drugs Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Gastrointestinal OTC Drugs Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Gastrointestinal OTC Drugs Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Gastrointestinal OTC Drugs Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Gastrointestinal OTC Drugs Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Gastrointestinal OTC Drugs Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Gastrointestinal OTC Drugs Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Gastrointestinal OTC Drugs Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Gastrointestinal OTC Drugs Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Gastrointestinal OTC Drugs Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Gastrointestinal OTC Drugs Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Gastrointestinal OTC Drugs Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Gastrointestinal OTC Drugs Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Gastrointestinal OTC Drugs Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Gastrointestinal OTC Drugs Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Gastrointestinal OTC Drugs Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Gastrointestinal OTC Drugs Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Gastrointestinal OTC Drugs Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Gastrointestinal OTC Drugs Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Gastrointestinal OTC Drugs Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Gastrointestinal OTC Drugs Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Gastrointestinal OTC Drugs Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Gastrointestinal OTC Drugs Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Gastrointestinal OTC Drugs Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Gastrointestinal OTC Drugs Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Gastrointestinal OTC Drugs Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Gastrointestinal OTC Drugs Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Gastrointestinal OTC Drugs Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Gastrointestinal OTC Drugs Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Gastrointestinal OTC Drugs Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Gastrointestinal OTC Drugs Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Gastrointestinal OTC Drugs Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Gastrointestinal OTC Drugs Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Gastrointestinal OTC Drugs Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Gastrointestinal OTC Drugs Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Gastrointestinal OTC Drugs Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Gastrointestinal OTC Drugs Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Gastrointestinal OTC Drugs Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Boehringer Ingelheim
  2. 8.1.1 Boehringer Ingelheim Company Information
  3. 8.1.2 Boehringer Ingelheim Business Overview
  4. 8.1.3 Boehringer Ingelheim Gastrointestinal OTC Drugs Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Boehringer Ingelheim Gastrointestinal OTC Drugs Product Portfolio
  6. 8.1.5 Boehringer Ingelheim Recent Developments
  7. 8.2 Perrigo
  8. 8.2.1 Perrigo Company Information
  9. 8.2.2 Perrigo Business Overview
  10. 8.2.3 Perrigo Gastrointestinal OTC Drugs Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Perrigo Gastrointestinal OTC Drugs Product Portfolio
  12. 8.2.5 Perrigo Recent Developments
  13. 8.3 Procter & Gamble
  14. 8.3.1 Procter & Gamble Company Information
  15. 8.3.2 Procter & Gamble Business Overview
  16. 8.3.3 Procter & Gamble Gastrointestinal OTC Drugs Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Procter & Gamble Gastrointestinal OTC Drugs Product Portfolio
  18. 8.3.5 Procter & Gamble Recent Developments
  19. 8.4 Purdue Pharma
  20. 8.4.1 Purdue Pharma Company Information
  21. 8.4.2 Purdue Pharma Business Overview
  22. 8.4.3 Purdue Pharma Gastrointestinal OTC Drugs Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Purdue Pharma Gastrointestinal OTC Drugs Product Portfolio
  24. 8.4.5 Purdue Pharma Recent Developments
  25. 8.5 Reckitt Benckiser
  26. 8.5.1 Reckitt Benckiser Company Information
  27. 8.5.2 Reckitt Benckiser Business Overview
  28. 8.5.3 Reckitt Benckiser Gastrointestinal OTC Drugs Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Reckitt Benckiser Gastrointestinal OTC Drugs Product Portfolio
  30. 8.5.5 Reckitt Benckiser Recent Developments
  31. 8.6 Bayer
  32. 8.6.1 Bayer Company Information
  33. 8.6.2 Bayer Business Overview
  34. 8.6.3 Bayer Gastrointestinal OTC Drugs Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Bayer Gastrointestinal OTC Drugs Product Portfolio
  36. 8.6.5 Bayer Recent Developments
  37. 8.7 GlaxoSmithKline
  38. 8.7.1 GlaxoSmithKline Company Information
  39. 8.7.2 GlaxoSmithKline Business Overview
  40. 8.7.3 GlaxoSmithKline Gastrointestinal OTC Drugs Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 GlaxoSmithKline Gastrointestinal OTC Drugs Product Portfolio
  42. 8.7.5 GlaxoSmithKline Recent Developments
  43. 8.8 Pfizer
  44. 8.8.1 Pfizer Company Information
  45. 8.8.2 Pfizer Business Overview
  46. 8.8.3 Pfizer Gastrointestinal OTC Drugs Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Pfizer Gastrointestinal OTC Drugs Product Portfolio
  48. 8.8.5 Pfizer Recent Developments
  49. 8.9 Johnson & Johnson
  50. 8.9.1 Johnson & Johnson Company Information
  51. 8.9.2 Johnson & Johnson Business Overview
  52. 8.9.3 Johnson & Johnson Gastrointestinal OTC Drugs Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Johnson & Johnson Gastrointestinal OTC Drugs Product Portfolio
  54. 8.9.5 Johnson & Johnson Recent Developments
  55. 8.10 Nestle
  56. 8.10.1 Nestle Company Information
  57. 8.10.2 Nestle Business Overview
  58. 8.10.3 Nestle Gastrointestinal OTC Drugs Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Nestle Gastrointestinal OTC Drugs Product Portfolio
  60. 8.10.5 Nestle Recent Developments
  61. 8.11 Sanofi
  62. 8.11.1 Sanofi Company Information
  63. 8.11.2 Sanofi Business Overview
  64. 8.11.3 Sanofi Gastrointestinal OTC Drugs Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Sanofi Gastrointestinal OTC Drugs Product Portfolio
  66. 8.11.5 Sanofi Recent Developments
  67. 8.12 Teva Pharmaceutical
  68. 8.12.1 Teva Pharmaceutical Company Information
  69. 8.12.2 Teva Pharmaceutical Business Overview
  70. 8.12.3 Teva Pharmaceutical Gastrointestinal OTC Drugs Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Teva Pharmaceutical Gastrointestinal OTC Drugs Product Portfolio
  72. 8.12.5 Teva Pharmaceutical Recent Developments
  73. 8.13 Abbott
  74. 8.13.1 Abbott Company Information
  75. 8.13.2 Abbott Business Overview
  76. 8.13.3 Abbott Gastrointestinal OTC Drugs Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Abbott Gastrointestinal OTC Drugs Product Portfolio
  78. 8.13.5 Abbott Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Gastrointestinal OTC Drugs Value Chain Analysis
  2. 9.1.1 Gastrointestinal OTC Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Gastrointestinal OTC Drugs Sales Mode & Process
  6. 9.2 Gastrointestinal OTC Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Gastrointestinal OTC Drugs Distributors
  9. 9.2.3 Gastrointestinal OTC Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst